Background.
were investigated using inulin clearance (C in ), para- ria, and electrolyte reabsorption rate.
Results. Gestational age of the 14 infants was 34±3
*Twin pregnancy; **two pregnancies.
weeks and birth weight 2018±620 g. During pregnancy, CsA trough blood level was 234±115 mg/l and plasma creatinine range was 96-136 mmol/l. Two chil-Introduction dren were excluded from the study because renal investigation led to a diagnosis of hereditary nephritis Cyclosporin (CsA) is a major anticalcineurin agent (one Alport syndrome, one familial dominant focal widely used in organ transplantation; its use results segmental glomerulosclerosis) that was retrospectively in significantly improved patient and graft survival completed in the mother. Renal function tests were in kidney, heart, liver, pancreas, and intestine finally performed in 12 children at 2.6±1.8 years transplantation. of age: BP 94±7/55±5 mmHg, C in 117±28 ml/ Several reports have shown that renal, endocrine, min/1.73 m2, C PAH 545±124 ml/min/1.73 m2, filtration and sexual functions may return to normal after transfraction 0.23±0.03, microalbuminuria 4.2±3.5 mg/ plantation. In pregnant transplanted women, immunommol. Electrolyte tubular reabsorption rates and urine suppressive therapy is generally maintained at the preconcentrating capacity were normal. pregnancy level, with appropriate adjustments accordConclusion. These results suggest that in children born ing to standard parameters including CsA trough blood to transplanted women taking CsA, renal function concentrations. Previous studies have shown that CsA develops normally despite prolonged exposure in crosses the placenta [1] and may accumulate in breast utero.
milk [2] . In addition, newborn infants exposed to CsA in utero often present with prematurity and/or low Keywords: children; cyclosporin; nephrotoxicity; birth weight for gestational age [3] [4] [5] [6] . pregnancy; renal function
Studies in experimental animals have demonstrated fetal toxicity, reduction of renal mass, and nephron deficit in association with high CsA doses [7] [8] [9] . Nevertheless, in humans, the incidence of neonatal complications and/or malformations are not CsA.
0.9% NaCl given over 12 min. This was followed by a sustaining infusion of 0.33 mg/kg BW per min polyfructosan and 0.25 mg/kg BW per min PAH in 0.9% NaCl (Braun perfusor, 0.25-0.5 ml/min according to BW ). After a 30-min
Subjects and methods
equilibration period, two to four 30-min urine collections were performed, which sometimes required bladder catheterization in children who had not attained adequate micMothers turition control. Blood samples were drawn at the midpoint of each urine collection. Plasma and urine creatinine, polyFourteen children were delivered from 13 pregnancies in 12 organ-transplanted women who received an immunosuppres-fructosan, and PAH were measured at each urine collection.
Electrolyte tubular reabsorption rates and spontaneous urinsion regime, including CsA, throughout their pregnancies. During pregnancy, the average CsA trough blood level was ary capacity tests were assessed concomitantly.
In the meantime, patients' blood pressure was routinely 234±115 (range 121-511) mg/l and the plasma creatinine (Pcr) range was 96-136 mmol/l. Pregnancy complications checked (DinamapB), as was proteinuria and renal ultra- sound at the time of the renal function study. Results are P-450 cytochrome system. Since its introduction, it has expressed as mean±standard deviation (median; range). become a major immunosuppressive agent, widely used Informed consent was obtained from all parents.
both in organ transplantation and autoimmune diseases [12] . However, its use is associated with a number of adverse events, such as nephrotoxicity, which may affect both native and transplanted kidneys. Two main
Results
forms of nephrotoxicity have been reported so far: acute reversible and chronic irreversible. Acute nephro- Table 2 displays the neonatal characteristics of the 12 toxicity is haemodynamically mediated, i.e. an increase study patients and the clinical data at the time of renal in renal vascular resistance is associated with a reducinvestigation. Preterm delivery occurred in 9/11 preg-tion in GFR and therefore in filtration fraction [13, 14] ; nancies (12 children) with a mean birth weight of these are dose-dependent phenomena [15] . The chronic 2018±620 g (2090; 1160-3280). The age at the time form is characterized by an irreversible renal dysfuncof renal investigation was 2.6 years (1.8; 1.0-6.9), BW tion associated with morphological injury [16 ] . 12.5±4.2 kg (11.7; 8.1-20.9), height 88.9±14.8 cm Tubular atrophy and interstitial fibrosis occur together (82.5; 72.5-115.2). With respect to growth develop-with vascular hyalinosis and glomerulosclerosis, somement, nine of the 12 children had normal body mass times associated with microcalcifications and mitoindex (BW/height2) and the remaining three were in chondrial enlargement [17] . the lower range. All 12 children had normal psychomoNevertheless, the CsA era has been characterized by tor development.
improved patient and graft survival, improved quality The results of renal function studies are summarized of life, and significant reductions in glucocorticoid in Table 3 . Electrolyte tubular reabsorption rates and dosage, which improvements have strongly favoured urinary concentration capacity tests were normal. pregnancy in transplanted women [18] . However, Plasma concentrations of sodium, potassium, chloride, because of substantial falls in serum CsA concentracalcium, and phosphate were normal, and no child tions during pregnancy, the CsA requirements are had proteinuria. Figure 1 shows The risk of fetal nephrotoxicity due to drugs adminCsA is a small neutral hydrophobic cyclic peptide of fungal origin, which is metabolized by the hepatic istered to the mother has been investigated both in ant reduction in renal mass [28, 29] . Such a pattern [315] [316] [317] [318] [319] has been reported in humans [30, 31] , and may com-13. Barros E, Boin M, Ajzen H, Ramos O, Schor N. Glomerular hemodynamics and hormonal participation on cyclosporine promise long-term renal function [32] . 
